FDA Inspection 1257448 — Joseph O. Lambert, M.D.
The FDA completed an inspection of Joseph O. Lambert, M.D. on Dec 16, 2024 in North Richland Hills, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 16, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North Richland Hills, TX (United States)
Additional Details
Clinical Investigator (CI)